Association of Target Therapy Gene Expression with Metastasizing of Clear-Cell Renal Cell Carcinoma


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We analyzed association of the levels of VEGFA, RAF1, and mTOR gene expression in the tissue of clear-cell renal cell carcinoma (ccRCC) with tumor metastasizing. Significant association with metastases was found only for VEGFA gene: OR=6.641, 95%CI=2.111-20.696. The risk of metastasis associated with reduced expression of VEGFA gene — 2.467, 95%CI=1.238-4.915. An association of VEGFA gene expression with the time to the metastasis appearance was revealed (p=0.0005). Reduced expression of the VEGFA gene is associated with reduction of the time to metastasis appearance; the median of this time is shifted from 46 to 2 months. Analysis of tumor samples with reduced expression of the VEGFA gene revealed association of increased expression of RAF1 (p=0.003) and mTOR genes (p=0.038) with metastasis.

About the authors

N. V. Apanovich

Research Center for Medical Genetics

Email: karpukhin@med-gen.ru
Russian Federation, Moscow

M. V. Peters

N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation

Email: karpukhin@med-gen.ru
Russian Federation, Moscow

P. V. Apanovich

Research Center for Medical Genetics

Email: karpukhin@med-gen.ru
Russian Federation, Moscow

A. S. Markova

N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation

Email: karpukhin@med-gen.ru
Russian Federation, Moscow

B. Sh. Kamolov

N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation

Email: karpukhin@med-gen.ru
Russian Federation, Moscow

V. B. Matveev

N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation; M. V. Lomonosov Moscow State University

Email: karpukhin@med-gen.ru
Russian Federation, Moscow; Moscow

A. V. Karpukhin

Research Center for Medical Genetics

Author for correspondence.
Email: karpukhin@med-gen.ru
Russian Federation, Moscow

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature